跳至主要内容
临床试验/NCT06263985
NCT06263985Unknown4 期

Prospective Analysis of Axis(TM) Solvent-dehydrate Dermal Allograft in the Treatment of Pelvic Organ Prolapse.

Michigan Institution of Women's Health PC2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2021年11月2日最近更新:
适应症
干预措施

试验速览

阶段
4 期
发起方
入组人数
50
试验地点
2
主要终点
Improvement in Anatomy

研究概览

简要总结

The goal of this study is to assess improvement in subjects who have undergone Axis Dermis, biologic mesh for pelvic organ prolapse repair. [describe participant population/health conditions]. The main question[s] it aims to answer are:

  • Is the leading edge of the prolapse above the hymen
  • Does subject notice a bulge Participants will undergo Axis Dermis pelvic organ prolapse repair procedure.

详细描述

This is a prospective single-arm study of 50 subjects undergoing pelvic organ prolapse repair using the Axis™ Dermis biologic mesh. They will be followed for a period of 3 years. A subgroup analysis is for patients with uterine prolapse and vaginal mesh hysteropexy.

Clinical examination including vaginal wall retraction with or without pelvic ultrasound, POP-Q, and also specific validated questionnaires at baseline, 1 month, 6 month, 12 month, 24 month and 36 month visits will be assessed.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 89 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Subjects with preoperative stage II or greater prolapse on the Pelvic Organ Prolapse Quantification System Assessment (POP-Q)
  • Subjects who have bothersome vaginal bulge based upon symptoms.
  • Subjects who undergo any type of Axis Dermis surgery (anterior, posterior, total, with or without a uterus).

排除标准

  • Subjects who are unable to follow-up.
  • Subjects who cannot complete the validated questionnaires.
  • Subjects that lack competency of the English language.
  • Subjects who decline to be part of the clinical trial.
  • Subjects who do not sign an informed consent.

研究组 & 干预措施

Subjects undergoing a pelvic organ prolapse repair procedure using Axis Dermis biologic mesh

Other

This is a single are which will be composed of subjects with Stage II or greater pelvic organ prolapse who have agreed to undergoing a pelvic organ prolapse repair procedure using Axis Dermis biologic mesh. They will undergo the procedure and be followed for a period of 3 years.

干预措施: Axis Dermis biologic mesh repair for pelvic organ prolapse (Device)

结局指标

主要结局

Improvement in Anatomy

时间窗: Preoperative to 3 years postoperative.

To assess improvement in anatomy with success defined as the leading edge of the prolapse is above the hymen, and no reintervention (surgery or pessary) for pelvic organ prolapse.

Improvement in function

时间窗: Preoperative to 3 years postoperative.

Determine improvement in function based on questionnaire Pelvic Floor Distress Inventory Q#3 "Do you usually have a bulge or something falling out that you can see or fell in the vaginal area?" Answered No, or if Yes: Not at all bothersome.

次要结局

  • Assess complications or untoward side effects.(intraoperative to 3 years postoperative)

研究者

发起方
Michigan Institution of Women's Health PC
申办方类型
Other
责任方
Principal Investigator
主要研究者

Salil Khandwala

Medical director

Michigan Institution of Women's Health PC

研究点 (2)

Loading locations...

相似试验